| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 926.24B | 890.88B | 897.60B | 904.88B | 790.93B |
| Gross Profit | 270.05B | 273.08B | 266.11B | 259.43B | 235.06B |
| EBITDA | 178.11B | 212.63B | 187.84B | 187.07B | 187.51B |
| Net Income | 131.97B | 131.35B | 110.45B | 113.50B | 122.19B |
Balance Sheet | |||||
| Total Assets | 1.42T | 1.28T | 1.15T | 1.18T | 1.08T |
| Cash, Cash Equivalents and Short-Term Investments | 543.24B | 533.45B | 408.12B | 401.87B | 351.28B |
| Total Debt | 202.91B | 192.03B | 164.65B | 174.67B | 175.93B |
| Total Liabilities | 531.38B | 456.07B | 401.24B | 394.07B | 420.51B |
| Stockholders Equity | 859.40B | 828.31B | 749.88B | 781.16B | 658.16B |
Cash Flow | |||||
| Free Cash Flow | 133.71B | 154.39B | 165.71B | 115.77B | 90.64B |
| Operating Cash Flow | 149.32B | 169.43B | 176.22B | 130.60B | 110.80B |
| Investing Cash Flow | -33.42B | -80.73B | 11.68B | -84.06B | -224.50B |
| Financing Cash Flow | -141.26B | -63.96B | -182.57B | -60.88B | 46.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $108.65B | 17.31 | 24.82% | 2.25% | 7.27% | 0.49% | |
74 Outperform | $10.90B | 26.50 | 23.75% | 1.25% | 8.41% | 25.60% | |
73 Outperform | $50.09B | 14.68 | 31.77% | 2.58% | 4.85% | 6.19% | |
72 Outperform | $4.75B | 17.71 | 25.50% | ― | 13.56% | 27.82% | |
68 Neutral | $26.13B | 17.90 | 14.84% | 1.46% | 6.95% | 1.11% | |
66 Neutral | $22.68B | 15.72 | 15.27% | 2.78% | -0.55% | -3.97% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |